You searched for "radiation"
Penile Mondor’s disease
Mondor’s disease is a rare, self-limiting entity characterised by subcutaneous chord like bands throughout the body. These bands arise due to phlebitis of the subcutaneous vessels. Penile Mondor’s disease (PMD) is an isolated superficial thrombophlebitis of the superficial dorsal vein...NOVOGLAN – Conservative Phimosis Management
iMEDicare are pleased to introduce Novoglan, an evidence-based, non-surgical solution for adult phimosis, now available as a reimbursable outpatient treatment under the NHS OPCS-4 code N30.5 (Stretching of the Prepuce), which maps to HRG LB56A. This presents an exciting opportunity...Establishing the Southwest Catheter Skills Course – a closed loop quality improvement project
The General Medical Council states that foundation year doctors should be able to carry out male and female urethral catheterisation safely under direct supervision [1]. A 2014 survey of medical students demonstrated that 40% and 64% had never performed male...
Prostatic urethral lift for obstructive median lobes: 12-month results of the MedLift study
As the various new BPH therapies try and mark out their role in the management of the condition, this is an interesting and useful addition to the literature. Patients were clinically screened for an obstructive median lobe on cystoscopy, which...New Report: The Impact of Incontinence on Families and Support Networks
The charity Bladder & Bowel UK has this week released the findings of a powerful new report. Supported by Attends, this research reveals the often-overlooked emotional, financial, and practical challenges faced by families and carers supporting someone with incontinence. From...
Intermittent vs. continuous hormonal therapy for metastatic prostate cancer
Continuous androgen deprivation therapy (cADT) is the standard management for metastatic prostate cancer (mPCa). Intermittent androgen deprivation therapy (iADT) is sought to have better quality of life (QoL) and adverse events profile during off-treatment period. This multicentre European randomised study...
Prostate Cancer Diagnosis – PSA, Biopsy and Beyond
The danger of many of the texts which deal with this rapidly changing field is that by the time the texts are published they are out of date. This book however remains fresh, in part because it acknowledges that there...
Smoking and urological health
European Urology Focus is a new sister journal to European Urology. It is peer-reviewed and will be published six times per year in electronic format. The first issue deals with smoking and urological diseases. It makes for very interesting reading...Viveca Biomed acquires Contrelle Activgard – European market launch imminent!
Viveca Biomed is pleased to announce the imminent relaunch of Contrelle Activgard across Europe, starting with the UK market.Urologist in the House!
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). This month, I am joined once again by Kassie Ball to discuss the...
The EP2 receptor – a novel target for prostate cancer?
This basic science paper sets out to evaluate the effects that celecoxib, a selective cyclo-oxygenase-2 (COX-2) inhibitor, have on prostate cancer cell lines and evaluated the mechanisms behind these effects. COX-2 induces the production of prostaglandins, which promote cell proliferation...
